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end TEL (5 aches), The rate of EGGs ordorad was also not different, (P - 
034) 
Conclusion: Tolemediclne interactive cardiology evaluations provide cltn. 
Ically accurate Information, but Important differences between TEL and FTF 
exist, A~urato lelomedlclne cardiology may be podormod without echo in 
many pediatric patients, 
~ Tolomedlcsl Interpretation at Neonatal 
Echocsrdlogrema: Impact on n General Podiatric 
Practice 
G,R, Rtlndolph, P,W, O'Le~tW, B,K, KhandhaflA, D,J, Hauler, J,B, Seward, 
M~/o C/in~e, Rochester' Mlnnpsof~, USA 
~la~Qml/~t; Cardiology amvl(~et, can be dllflcull to provide in nlrol eros#, This 
study was performed to evaluate the InterpretAtion ~t remote site neonatal 
o0horArdlogmms using teal-lima talamedletne, 
M~fhoda,' Adult aonagmphem psdormed studios requestnd by general 
pedllllflctana At a site 3BO miles from th~ potll~lrlC ollrglolegy ~enter (hub), 
PrellmlnAty images ware recorded ~nd transmitted from onba~da to A pediAlna 
~hoosrdlologtM ~t the hNb ~.Ising AT,1 system (1 ,B megabitslaee), Additl,.)nal 
teal,lima scans ware then dlrofltod end mnnltored by the reviewer to complete 
each .tudy, 
R~lte:  115 T,1 n0,bo~ardlograms ware pedormod on g0 neonAleS, Me, 
dian age was ~ days, 90% (89/90) oi initial erho~ardlograma were pedermod 
u~nlly or emergantly, Tmnsmltled Imegaa provided Adaq~nto diagnnstic in- 
formation in all pts. T.1 diagnoses ware confirmed in ~II pie with nubseqtmnt 
slandard !eating (N ,= 12), T.I echo findings dtanged medical management 
nr outpatient followup In 61% (aS/SO), An Immediate change in management 
o~urred qn 26% (23/90), B babies were itavcroly m/Anotlo And 1 was hypoten- 
slw due to CHD (Congenital Heart Disease), %1 echo findings guided local 
stsblllzafton and eady transfer in 4, Unnecessan/transfer was avoided in 2 
cyanntie n~nates whose cardiac mallormatlons ware not doers1 dependent. 
Con~uston: 1",1 echo provides accurate diagnostic data tn neonates, 
Rapid tale.diagnosis facilitates cam oi sick neonates with possible CHD 
In the pitman/care se~11ng, Unnecossaw long distance transfers can be 
avoided, Reel.time, teto.echo~ardlography etle~tlvaly extends tortlaq/pedi. 
Atdc cardiology Into prtmaq/caro settings, 
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- ' Renal Response to Volume Expansion In 
Moderate Heart Failure 
R, W(llenbrock, M, Scheuormann, G. Thlbault, R. Diotz. 
Fran,.',.Vo/h~rd.Klinik, Bert/n, Germany 
In heart failure, the release of ANP is impaired along with an activated 
renin-anglotonsin system, We tested the hypothesis that ANP release is 
angiotensin It- dependent and studtod the effect el ACE-inhibition (ramiprilat 
50 m.0,/kg) and ATl-blockade (valssrtan 0.3 mg/kg) on ANP release and on 
the renal response to acute volume expansion (5 ml/5 mln hyperoncontic 
solution) in rats with shunt-induced moderato heart failure. 
ANP plasma levels were increased in shunted rats (397 ~ 39 pmoR 
vs. 55 ~ 8 in controls rats, p ~ 0.001) at baseline. Alter acute volume 
expansion, the ANP release was impaired In shunted rats (68 L 4 vs. 135 
7 pmel/1, p .  0.05). Natriurests and diuresis were blunted at baseline and 
after acute volume expansion (1250 ~ 126 vs. 2753 L 1;6 .I/60 min, p .  
0.001). ACE-Inhibition end ATl-antagonlst did not influence hemodynamic 
parameters. Acute ACEI increased natnuresis end diuresis at baseline in 
heart failure rats compared to placebo treated rats (211 50 vs. 95 ~ 15 ttl/20 
mln, p -- 0.05). After acute volume expansion, ANP plasma levels significantly 
increased with ACEI end ATl-antagonist in shunted rats, inducing a further 
release at 190 9 i- 86.9 and 250,0 :t: 48.5 vs. 67.7 :~ 32.8 pmol/I with placebo 
(p < 0.05). N-terminal ANP increased similarly, confirming that the release of 
ANP was modified. Natdurosis and diuresis were enhanced by ACE-inhibition 
(2345 -L 332) and ATl-blockade (1860 :t 180 vs. 1250 ~. 126/=L'60 min, p 
• 0.01). Our results demonstrate that acute anglotensin inhibition restores 
ANP release and renal responses alter acute volume expansion in shunted 
rats. This suggests a new site of interaction between the angiotensin and the 
ANP system. 
• Renln-Anglotensln Inhibition Prevents System 
Early but Not Late Remodeling of the Left 
Ventricle In Pacing.induced Cardlomyopsthy 
H, Knwal, A, Mohan, C, Ltang. University of Rochester, Rochester, NY, USA 
B~ckground: The ronin.anglotensln system (RAS) play~ an important 
in leH ventdeular (LV) remedellng In congestive heart failure (CHF); how- 
ever, the results of RAS inhibition on LV remodeling have been coolltrtin9 
We speculate that the differences in results may be related to timing oi 
Interventions In CHF, 
Mefhod~: To study whether the eff~¢la of RAS inhibition may differ at van- 
cue stages of development o! CHF, we. measured LV end.diastolic d imen~ 
(EDD, ram) end LV fraalional shortening (FS, %) before (B) And Alter 2, 
4, 6, 8 weeks of pl'!elng.lnduced CHF (360 bpm for 8 wQ~_ka) in ¢on.soou~ 
rabbits, RAS inhibition wAS achieved by administration oi both quinapnl (Q, 
10 mg/kg), an anglotensin.convertlng enzyme inhibitor and foMrtan (L. 50 
mg/kg), an AT1 engiotansln II receptor bl(,~kat, 
Re-~t~/fsl.' V~tuoa worn compared to Sham and untreated CHF animals 
ChAnBos in EDD . ChAnl~a in F$ 
(mm)j eP  (~,1 , . . ,  ~ 
II 2w 4v~ 6~, Rw II 2w 4w 6w #~ (N=¢'me=:klP°qP) 
Conc/u.won, Rapid ventoculat pacing produces acute LV dilabon and 
systolic dyslunclion, RAS inhibitmn delays the onset of these changes m 
eady CHF, but deos not prevent LV remodeling in chronic CHE 
• Anglotensln II l~tpe Receptor 1 Blockade: 
Myocardial Fibrosis, Stiffness, and Flmction After 
In|station In the Rat 
H,M. That, H.H.T. Van, MA. GabeUa, S. Goldman, T.E Rays l'bcson VAA~ 
,'zna Umve~it)' Heart Centre bnlversily ot Arizona. 7boron. AZ. USA 
Background: We examined the effects of specific angiotensm It type 1 (AT1) 
receptor blockade on myocardial fibrosis, stiffness, and function after my- 
ocardial infamtion (MI) in the rat. 
Methods and Results: Rats were randomized to Iosartan or placebo 1 day 
alter MI and treated for 8 weeks. In sham and MI rats Iosartan decreased 
(P ~ 0.05) LV and RV weights, mean aortic and LV systolic pressures. 
LV end-diastolic pressure iEDP) was increased (P < 0.05) tn MI vs sham 
rats. Losartan decreased (P -. O05) LV-EDP in MI but not m sham rats. 
Maximal developed tension (DT) and peak rate of tension nse (+dTidt) were 
decreased (P .  0.05) in MI vs sham (DT: 1.64 ~ 0.46 vs 3.45 • 1.11 oj'mm z: 
dTldt: 15.9 ~ 44 vs 345 ± 12.0 oj'mm~/sec). Losartan decreased DT and 
+tiT/dr in sham rats and increased DT and +dTldt in MI rats resulting in a 
significant interaction (P = 0.043 and P = 0.045, respectively). The peak rate 
of tension decline decreased (P - 0.05) in MI vs sham rats ( 10.6 ± 3.8 vs 
- 16.2 ~ 5.4 g/mm~/sec) with a trend to iocreaso by Iosartan in MI rats ( 2.5 
5.1 gtmm'~/sec). Interstitial fibrosis increased (P < 005) in MI vs sham 
and decreased (P < 0.05) with Iosartan. Ik%'ocardiat s iffness increased (P - 
0.05) after MI but normalized (P .: 0.05) with Iosartan. 
Conclusions: Alter MI, ATt receptor blockade has benehcial effects on my- 
ocardial contractility and normalizes myocardial stiffness with an assocmted 
reduction in myocardial fibrosis. 
• Angiotensin Converting Enzyme Inhibition 
Increases Cardiac Adenylycyclase Expression in 
Congest;ve Heart Failure 
T, Anzai, M. Gao. NC. Lai, HK. Hammond. VAMC-San Diego and UCSD. 
La Jolla. CA. USA 
Background: Heart failure is associated witn aec~eased adenylycyclase iAC) 
activity and downregutaticn o! AC mRNA. particularly type VI (ACw). The 
effect of ACE inhibition on AC, a pivotal regulating element in transmembrane, 
signaling, is unknown. 
Methoos: We studied 23 pigs (51 ~.- 6 kg): 11 controls: 6 received no 
treatment (CON) and 5 received lisinopdl iLlS, 0.5 mg/kg/d iv for 10d) and 
12 paced from the LV (220 bpm, 20d): 6 received no treatment (HF) and 6 
received Usinopril for the final 10 days (HF/L). Heart failure was documented 
(pacers off) by decreased LV fractional shortening (p < 0.001 ) and increased 
left atrial pressure (p < 0.001). We measured LV AC activity, and mRNA 
content of ACw, the predominant AC isoform in pig heart. 
